1. Home
  2. CRVS vs TBRG Comparison

CRVS vs TBRG Comparison

Compare CRVS & TBRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRVS
  • TBRG
  • Stock Information
  • Founded
  • CRVS 2014
  • TBRG 1979
  • Country
  • CRVS United States
  • TBRG United States
  • Employees
  • CRVS N/A
  • TBRG N/A
  • Industry
  • CRVS Biotechnology: Pharmaceutical Preparations
  • TBRG
  • Sector
  • CRVS Health Care
  • TBRG
  • Exchange
  • CRVS Nasdaq
  • TBRG NYSE
  • Market Cap
  • CRVS 305.4M
  • TBRG 351.8M
  • IPO Year
  • CRVS 2016
  • TBRG N/A
  • Fundamental
  • Price
  • CRVS $4.17
  • TBRG $20.82
  • Analyst Decision
  • CRVS Strong Buy
  • TBRG Buy
  • Analyst Count
  • CRVS 4
  • TBRG 3
  • Target Price
  • CRVS $15.00
  • TBRG $23.67
  • AVG Volume (30 Days)
  • CRVS 437.5K
  • TBRG 157.8K
  • Earning Date
  • CRVS 08-12-2025
  • TBRG 08-11-2025
  • Dividend Yield
  • CRVS N/A
  • TBRG N/A
  • EPS Growth
  • CRVS N/A
  • TBRG N/A
  • EPS
  • CRVS N/A
  • TBRG N/A
  • Revenue
  • CRVS N/A
  • TBRG $345,737,000.00
  • Revenue This Year
  • CRVS N/A
  • TBRG $5.15
  • Revenue Next Year
  • CRVS N/A
  • TBRG $5.25
  • P/E Ratio
  • CRVS N/A
  • TBRG N/A
  • Revenue Growth
  • CRVS N/A
  • TBRG 3.56
  • 52 Week Low
  • CRVS $2.47
  • TBRG $9.75
  • 52 Week High
  • CRVS $10.00
  • TBRG $32.00
  • Technical
  • Relative Strength Index (RSI)
  • CRVS 46.72
  • TBRG 33.51
  • Support Level
  • CRVS $4.58
  • TBRG $22.99
  • Resistance Level
  • CRVS $4.98
  • TBRG $23.30
  • Average True Range (ATR)
  • CRVS 0.23
  • TBRG 0.82
  • MACD
  • CRVS -0.02
  • TBRG -0.10
  • Stochastic Oscillator
  • CRVS 8.52
  • TBRG 13.46

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).

About TBRG TRUBRIDGE INC

TruBridge Inc is a provider of healthcare solutions and services for community hospitals, clinics, and other healthcare systems. It provides services such as Electronic health records & information systems, revenue cycle management, population health, and data management, etc. The segments of the company are Revenue Cycle Management (RCM), (ii) Electronic Health Records (EHR), and (iii) Patient Engagement The company derives maximum revenue from the RCM segment.

Share on Social Networks: